Lung Ultrasound in Detection of Extravascular Lung Water in Septic Patients.
NCT ID: NCT03676699
Last Updated: 2018-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2018-03-30
2018-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Acute Kidney Injury in Patients With Sepsis Using Venous Excess Ultrasound Score
NCT06176807
The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial
NCT05569798
Quantitative Ultrasound Assessment of Abdominal Cavity Space
NCT06634732
Sepsis in Respiratory Intensive Care Unit
NCT05240157
Early Diagnosis of ARDS in Mechanically Ventilated Patient Using LUS Score in Comparison With CT
NCT06971042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound chest
Ultrasound detection of extravascular lung water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with severe sepsis or septic shock according to the third international consensus definition (sepsis-3).
* All of them underwent major abdominal oncologic surgeries.
Exclusion Criteria
* Patients with BMI\>35.
* Patients who suffered from chronic lung disease.
* History of cardiac or renal problems.
* Patients with lung cancer or pulmonary metastases.
* Patients with inserted chest tubes.
* Presence of subcutaneous emphysema.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ehab Hanafy Shaker
lecturer of anesthesia ,critical care and pain medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ehab H Shaker, MD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute- Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesia and Pain medicine.National Cancer Institute
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Lung ultrasonography for the assessment of rapid extravascular water variation: evidence from hemodialysis patients.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ehab-Walaa.Ultrasound
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.